Next-Generation Synthetic Breast Tissue Image Generation System

A novel system and method for generating synthetic breast tissue images with enhanced tissue visibility, utilizing advanced machine learning and physics-based models to overcome limitations of traditional high-density element suppression techniques.

Traditional breast imaging techniques, such as tomosynthesis, often struggle with obtrusive high-density elements, which can obscure critical tissue structures. The original patent addressed this issue through high-density element suppression, but limitations remain. The new inventive concept addresses these limitations by introducing advanced machine learning and physics-based models to generate synthetic breast tissue images with enhanced tissue visibility.

The next-generation system comprises a neural network trained on a dataset of high-density element-suppressed images to predict suppressed tissue structures. The system also includes a processing module to generate a synthesized image with enhanced tissue visibility. Alternatively, a generative adversarial network can be trained on paired high-density element-suppressed and corresponding high-density element-enhanced images to generate a synthesized image. The system can also utilize a database of high-density element-suppressed images and a machine learning model to predict suppressed tissue structures. Additionally, a high-density element detection module can identify regions of high-density elements in an input image, and a processing module can apply a physics-based model to simulate the suppression of high-density elements in the identified regions.

The new inventive concept introduces the use of advanced machine learning models, such as neural networks and generative adversarial networks, to predict suppressed tissue structures and generate synthetic breast tissue images with enhanced tissue visibility. This represents a significant departure from traditional high-density element suppression techniques, offering improved image quality and diagnostic accuracy.

Alternative embodiments may include the use of other machine learning models, such as deep learning-based image enhancement algorithms, or the integration of additional data sources, such as patient-specific information or multi-modal imaging data. Variations may also include the application of the inventive concept to other medical imaging modalities, such as MRI or CT scans.

The next-generation synthetic breast tissue image generation system has significant commercial potential in the medical imaging industry, particularly in the areas of breast cancer screening and diagnosis. The system's ability to generate high-quality images with enhanced tissue visibility can improve diagnostic accuracy and patient outcomes, making it an attractive solution for healthcare providers and medical device manufacturers.